CKPT: Checkpoint Therapeutics, Inc. Stock

by  •  • Comments Off on CKPT: Checkpoint Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 344.71
Enterprise Value ($M) 311.67
Book Value ($M) 16.30
Book Value / Share 0.20
Price / Book 21.15
NCAV ($M) 16.30
NCAV / Share 0.20
Price / NCAV 21.15

Profitability (mra)
Return on Invested Capital (ROIC) -3.47
Return on Assets (ROA) -4.72
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.91
Current Ratio 1.91

Balance Sheet (mrq) ($M)
Current Assets 34.16
Assets 34.16
Liabilities 17.87
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.04
Operating Income -56.17
Net Income -56.24
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -31.10
Cash from Investing 0.00
Cash from Financing 32.78

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
5 days ago 13G/A Armistice Capital, Llc 4.99 -16.37
5 days ago 13G/A Glazer Capital, Llc 3.81 2.52
03-17 13G Beryl Capital Management LLC 9.90
03-11 13D/A Fortress Biotech, Inc. 11.20 0.27

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐TRANSITION REPORT PUR
2025-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐TRANSITION REPORT
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-16 37,093 256,545 14.46
2025-05-15 227,754 844,431 26.97
2025-05-14 124,382 625,036 19.90

(click for more detail)

Similar Companies
CGEN – Compugen Ltd. CGTX – Cognition Therapeutics, Inc.
CING – Cingulate Inc. CLDX – Celldex Therapeutics, Inc.
CLNN – Clene Inc.


Financial data and stock pages provided by
Fintel.io